These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11680669

  • 1. Pharmacokinetics of rizatriptan in healthy elderly subjects.
    Musson DG, Birk KL, Panebianco DL, Gagliano KD, Rogers JD, Goldberg MR.
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
    [Abstract] [Full Text] [Related]

  • 2. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
    Peck RW, Seaber EJ, Dixon RM, Layton GR, Weatherley BC, Jackson SH, Rolan PE, Posner J.
    Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
    [Abstract] [Full Text] [Related]

  • 3. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP, Halpin RA, Geer LA, Ellis JD, Liu L, Cheng H, Chavez-Eng C, Matuszewski BK, Varga SL, Guiblin AR, Rogers JD.
    Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
    Swan SK, Alcorn H, Rodgers A, Hustad CM, Ramsey KE, Woll S, Skobieranda F.
    J Clin Pharmacol; 2006 Feb; 46(2):172-8. PubMed ID: 16432269
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the bioequivalence and pharmacokinetics of two formulations of rizatriptan after single oral administration in healthy volunteers.
    Chen J, Jiang WM, Xie YL, Jin L, Mei N, Liang XG.
    Arzneimittelforschung; 2005 Feb; 55(7):355-8. PubMed ID: 16080273
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.
    Fraser IP, Han L, Han TH, Li CC, Hreniuk D, Stoch SA, Wagner JA, Linder S, Winner P.
    Headache; 2012 Apr; 52(4):625-35. PubMed ID: 22289113
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and food interaction of MK-462 in healthy males.
    Cheng H, Polvino WJ, Sciberras D, Yogendran L, Cerchio KA, Christie K, Olah TV, McLoughlin D, James I, Rogers JD.
    Biopharm Drug Dispos; 1996 Jan; 17(1):17-24. PubMed ID: 8991488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K.
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [Abstract] [Full Text] [Related]

  • 13. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA, Rosseel MT, Bernheim J.
    Int J Clin Pharmacol Res; 1988 Apr; 8(6):463-70. PubMed ID: 2908109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY, Moon JD, Lee YB.
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.
    Wong SL, Cao G, Mack RJ, Granneman GR.
    Clin Pharmacol Ther; 1997 Aug; 62(2):157-64. PubMed ID: 9284851
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [Abstract] [Full Text] [Related]

  • 19. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M, Chang S, Hellriegel ET.
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
    Emmons GT, Argenti R, Martin LL, Martin NE, Jensen BK.
    J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.